S.I.N. Implant System

K170392 · S.I.N. – Sistema DE Implante Nacional S.A. · DZE · Dec 1, 2017 · Dental

Device Facts

Record IDK170392
Device NameS.I.N. Implant System
ApplicantS.I.N. – Sistema DE Implante Nacional S.A.
Product CodeDZE · Dental
Decision DateDec 1, 2017
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3640
Device ClassClass 2
AttributesTherapeutic

Intended Use

S.I.N. Dental Implant System is intended for placement in the maxillary or mandibular arch to provide support for single-unit or multi-unit restorations. When a one-stage surgical approach is applied, the S.I.N. Dental Implant System is intended for immediate loading when good primary stability is achieved and with appropriate occlusal loading. Implants with lengths less than 7 mm are intended for delayed loading only.

Device Story

S.I.N. Dental Implant System comprises threaded, cylindrical root-form implants (Unitite, Unitite Compact, Strong SW CM) and associated abutments. Implants are surgically placed in maxillary or mandibular bone by dental clinicians to support single or multi-unit restorations. System utilizes Morse taper connections; components are fabricated from commercially pure titanium, titanium alloy, cobalt-chromium, or polycarbonate. Surface treatments include acid-etching and hydroxyapatite (HA) coating. Device provides structural anchorage for prosthetic restorations (crowns, bridges, overdentures). Clinical benefit includes restoration of chewing function and dental aesthetics. No software or automated algorithms involved.

Clinical Evidence

No clinical data were included in this submission. Substantial equivalence is supported by non-clinical bench testing, including biocompatibility (ISO 10993 series), sterilization validation (ISO 11137, ISO 17665), shelf-life testing (ASTM F1980, F1929, F88), and surface area/insertion performance analysis.

Technological Characteristics

Threaded, cylindrical root-form dental implants and abutments. Materials: CPTi Grade 4, Ti-6Al-4V, CoCr, polycarbonate. Surface: Acid-etched and HA-coated. Connection: Morse taper. Dimensions: Diameters 2.9-6.0 mm, lengths 5-15 mm. Sterilization: Radiation (ISO 11137) and steam (ISO 17665). No software or electronic components.

Indications for Use

Indicated for patients requiring single or multi-unit dental restorations in the maxillary or mandibular arch. Suitable for immediate loading when primary stability and appropriate occlusal loading are achieved; implants <7 mm length restricted to delayed loading.

Regulatory Classification

Identification

An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.

Special Controls

*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health and Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. December 5, 2017 S.I.N. - Sistema de Implante Nacional S.A. Linda K. Schulz Regulatory Affairs PaxMed International, LLC 12264 El Camino Real. Suite 400 San Diego, California 92130 Re: K170392 Trade/Device Name: S.I.N. Dental Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: November 2, 2017 Received: November 3, 2017 Dear Linda K. Schulz: This letter corrects our substantially equivalent letter of December 1, 2017. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, # Mary S. Runner -S for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ #### DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration # Indications for Use Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below. 510(k) Number (if known) K170392 Device Name S.I.N. Dental Implant System Indications for Use (Describe) S.I.N. Dental Implant System is intended for placement in the maxillary or mandibular arch to provide support for single-unit or multi-unit restorations. When a one-stage surgical approach is applied, the S.I.N. Dental Implant System is intended for immediate loading when good primary stability is achieved and with appropriate occlusal loading. Implants with lengths less than 7 mm are intended for delayed loading only. Type of Use *(Select one or both, as applicable)* | <span> <span style="font-size: 16px;">☑</span> Prescription Use (Part 21 CFR 801 Subpart D) </span> | <span> □ Over-The-Counter Use (21 CFR 801 Subpart C) </span> | |---------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------| |---------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------| #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # 510(k) Summary S.I.N. - Sistema de Implante Nacional S.A. S.I.N. Dental Implant System K170392 December 1, 2017 ## ADMINISTRATIVE INFORMATION | Manufacturer Name | S.I.N. – Sistema de Implante Nacional S.A.<br>Avenida Vereador Abel Ferreira, 1100<br>São Paulo, São Paulo<br>03340-000 Brazil<br>Telephone: +55-11-21693000 ext 3236 | | |---------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------| | Official Contact | Dênis Oliveira | Quality and Regulatory Manager | | Representative/Consultant | Linda K. Schulz, BSDH, RDH<br>Floyd G. Larson, MS, MBA<br>PaxMed International, LLC<br>12264 El Camino Real, Suite 400<br>San Diego, CA 92130<br>Telephone: +1 (858) 792-1235<br>Fax: +1 (858) 792-1236<br>Email: lschulz@paxmed.com<br>flarson@paxmed.com | | ## DEVICE NAME AND CLASSIFICATION | Trade/Proprietary Name | S.I.N. Dental Implant System | |----------------------------|--------------------------------------------| | Common Name | Dental implant | | | Dental implant abutment | | Classification Name | Implant, endosseous, root form | | | Endosseous dental implant abutment | | Classification Regulations | 21 CFR 872.3640, 21 CFR 872.3630, Class II | | Product Code | DZE, NHA | | Classification Panel | Dental Products Panel | | Reviewing Branch | Dental Devices Branch | ## PREDICATE DEVICE INFORMATION | Primary Predicate | | | |----------------------|----------------------------------------------------|-------------------------------------| | K051859 | Sistema de Implante Nacional Dental Implant System | Sistema de Implante Nacional, Ltda. | | Reference Predicates | | | | K120414 | OsseoSpeedTM Plus | Astra Tech AB | | K072570 | NobelActive Multi Unit Abutment | Nobel Biocare AB | | K081653 | MDI MII 2.9 mm Implants | IMTEC Corporation | | K101225 | Promimic Dental Implant | Promimic AB | | K092035 | Bicon Implants with a 2.5mm Internal Connection | Bicon, L.L.C | {4}------------------------------------------------ #### INDICATIONS FOR USE S.I.N. Dental Implant System is intended for placement in the maxillary or mandibular arch to provide support for single-unit or multi-unit restorations. When a one-stage surgical approach is applied, the S.I.N. Dental Implant System is intended for immediate loading when good primary stability is achieved and with appropriate occlusal loading. Implants with lengths less than 7 mm are intended for delayed loading only. #### DEVICE DESCRIPTION The subject device consists of four Morse taper connection product lines: Unitite, Unitite Compact, and Strong SW CM. All implants are threaded cylindrical root-form designs. The Unitite provided with an acid-etched and HA surface, the Strong SW CM is provided with an acid-etched surface, Each product line has abutments available in multiple designs (temporary, cementable, angled, UCLA, ball, multi-unit). Subject device abutments are straight only. Unitite implants are available in six implant body diameters (2.9. 3.5. 4.0. 4.3. 5.0 and 6.0 mm) and eight lengths (5, 6, 7, 8.5, 10, 11.5, 13, and 15 mm). Strong SW CM implants are available in four implant diameters (3.5, 3.8, 4.5.5.0 mm) and five lengths (8.5. 10. 11.5. 13. and 15 mm). Unitite abutments are available in five prosthetic platform diameters (3.3, 3.5, 4.0, 4.5, and 4.8 mm). Strong SW CM abutments are available in four prosthetic platform diameters (3.3, 3.5, 4.5 and 4.8 mm). Subject Device components are made of commercially pure titanium, titanium alloy, cobalt-chromium, or polycarbonate. | IMPLANT | Body<br>Diameter<br>mm | Platform<br>Diameter<br>mm | Length<br>mm | |-----------------|------------------------|----------------------------|-----------------------| | Unitite Slim | 2.9 | 2.9 | 10, 11.5, 13 | | Unitite | 3.5 | 3.5 | 8.5, 10, 11.5, 13, 15 | | | 4.3 | 4.3 | 8.5, 10, 11.5, 13, 15 | | | 5.0 | 5.0 | 8.5, 10, 11.5, 13, 15 | | Unitite Compact | 4.0 | 4.0 | 5, 6, 7 | | | 5.0 | 5.0 | 5, 6, 7 | | | 6.0 | 6.0 | 5, 6, 7 | | Strong SW CM | 3.5 | 3.5 | 8.5, 10, 11.5, 13, 15 | | | 3.8 | 3.8 | 8.5, 10, 11.5, 13, 15 | | | 4.5 | 4.5 | 8.5, 10, 11.5, 13, 15 | | | 5.0 | 5.0 | 8.5, 10, 11.5, 13, 15 | #### PERFORMANCE DATA Non-clinical testing data submitted or relied upon to demonstrate substantial equivalence included: radiation sterilization validation according to ISO 11137-1 and 11137-2 and steam sterilization according to ISO 17665-1 and ISO 17665-2, demonstrating a sterility assurance level (SAL) of 10 %; Limulus amebocyte lysate (LAL) testing according to AANSI/AAMI ST 72: Shelf life testing according to ASTM F1980. ASTM F1929. and ASTM F88/F88M; biocompatibility testing according to ISO 10993-3 (genotoxicity), ISO 10993-5 (cytotoxicity), ISO 10993-6 (implantation), ISO 10993-10 (sensitization and irritation), and ISO 10993-11 (systemic toxicity) demonstrating acceptable biocompatibility; surface area analysis showing substantial equivalence to a predicate; and performance testing for insertion to show substantial equivalence to the predicate. No clinical data were included in this submission. ## EQUIVALENCE TO MARKETED DEVICE The subject device is substantially equivalent in indications and design principles to the predicate devices shown above. Below are summary tables comparing the Indications for Use and the technological characteristics of the subject device and the predicate devices. {5}------------------------------------------------ #### Comparison of Indications for Use Statements | Subject Device | | |---------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | K170392<br>S.I.N. Implant System<br>SIN - Sistema de Implante<br>Nacional S.A. | S.I.N. Dental Implant System is intended for placement in the maxillary or mandibular arch to provide support for<br>single-unit or multi-unit restorations. When a one-stage surgical approach is applied, the S.I.N. Dental Implant<br>System is intended for immediate loading when good primary stability is achieved and with appropriate occlusal<br>loading. Implants with lengths less than 7 mm are intended for delayed loading only. | | Primary Predicate Device | | | K051859<br>Sistema de Implante<br>Nacional Dental Implant<br>System<br>SIN - Sistema de Implante<br>Nacional, Ltda. | The Sistema de Implante Nacional Dental Implant System is intended to be surgically placed in the bone of the<br>maxillary and/or mandibular arch to provide support for crowns, bridges or overdentures. Implants may be placed<br>immediately after tooth extraction or following bone healing. Restorations supported by two or more Sistema<br>de Implante Nacional implants may be loaded immediately after implant placement if primary implant stability<br>has been achieved. | | Reference Predicate Devices | | | K120414<br>OsseoSpeed™ Plus<br>Astra Tech AB | Implants: The Astra Tech Dental Implants are intended for both one- and two-stage surgical procedures in the<br>following situations and with the following clinical protocols:<br>• replacing single and multiple missing teeth in the mandible and maxilla,<br>• immediate placement in extraction sites and in situations with a partially or completely healed alveolar<br>ridge,<br>• especially indicated for use in soft bone applications where implants with other implant surface<br>treatments may be less effective,<br>• immediate loading in all indications, except in single tooth situations on implants shorter than 8 mm, or<br>in soft bone (type IV) where implant stability may be difficult to obtain and immediate loading may not<br>be appropriate.<br>The intended use for OsseoSpeed™ Plus 3.0S is limited to replacement of maxillary lateral incisors and<br>mandibular incisors.<br>Abutments: Astra Tech Implant System Plus abutments are intended to be used in conjunction with Astra Tech<br>Implant System Plus in fully edentulous or partially edentulous maxillary and/or mandibular arches to provide<br>support for crowns, bridges or overdentures.<br>Atlantis Abutments: The Atlantis™ Abutment is intended for use with an endosseous implant to support a<br>prosthetic device in a partially or completely edentulous; patient. It is intended for use to support single and<br>multiple tooth prostheses, in the mandible or maxilla. The prosthesis can be cemented, screw retained or friction<br>fit to the abutment. The abutment screw is intended to secure the abutment to the endosseous implant.<br>The Atlantis™ Crown Abutment in Zirconia is intended for use with an endosseous; implant to function as a<br>substructure that also serves as the final restoration, in partially or completely edentulous; patients. The prosthesis<br>is screw retained. The abutment screw is intended to secure the crown abutment to the endosseous implant. | | K072570<br>NobelActive Multi Unit<br>Abutment<br>Nobel Biocare AB | NobelActive Multi Unit Abutment is a pre-manufactured prosthetic component directly<br>connected to the endosseous dental implant and intended for use as an aid in prosthetic<br>rehabilitation. | | K081653<br>MDI MII 2.9 mm Implants<br>IMTEC Corporation | The MII Implant is intended to support single or multi-unit restorations in both long-term and temporary<br>applications throughout the maxillary and mandibular arches. The MII implant is indicated for immediate loading<br>when good primary stability is achieved. Additionally, this device will permit stability and long term fixation of<br>upper and lower dentures in edentulous cases. | | K101225<br>Promimic Dental Implant<br>Promimic AB | The Promimic AB, Promimic Dental Implant is intended for surgical placement into the bone of upper/lower jaw<br>arches as a permanent anchorage for prosthetic devices and to restore chewing function. The Promimic Dental<br>Implant can be immediately loaded only with good primary stability and appropriate occlusal loading. The<br>Promimic Dental Implants are only to be used with straight abutments. | | K092035<br>Bicon Implants with a 2.5mm<br>Internal Connection<br>Bicon, L.L.C. | The Bicon implant is designed for use in edentulous sites in the mandible or maxilla for support of a complete<br>denture prosthesis, a final or intermediate abutment for fixed bridgework or for partial dentures, or as a single<br>tooth replacement. | {6}------------------------------------------------ # Comparison of Technological Characteristics | | Subject Device | Primary<br>Predicate Device | | | Reference<br>Predicate Devices | | | |-----------------------------------|--------------------------------------------------|----------------------------------------------------------|---------------------------------------------|------------------------------------|--------------------------------|-----------------------------------|-------------------------------------------------------| | | | K051859 | K120414 | K072570 | K081653 | K101225 | K092035 | | | S.I.N. Implant<br>System | Sistema de Implante<br>Nacional<br>Dental Implant System | OsseoSpeed™ Plus | NobelActive Multi<br>Unit Abutment | MDI MII 2.9 mm<br>Implants | Promimic<br>Dental Implant | Bicon Implants with<br>a 2.5mm Internal<br>Connection | | | S.I.N. – Sistema de<br>Implante Nacional<br>S.A. | S.I.N. – Sistema de<br>Implante Nacional,<br>Ltda. | Astra Tech AB | Nobel Biocare AB | IMTEC Corporation | Promimic AB | Bicon, L.L.C. | | DESIGN | | | | | | | | | Prosthesis Attachment | Screw-retained<br>Cement-retained | Screw-retained<br>Cement-retained | Screw-retained<br>Cement-retained | Screw-retained | Cement-retained | Screw-retained<br>Cement-retained | Screw-retained<br>Cement-retained | | Restoration | Single-unit<br>Multi-unit | Single-unit<br>Multi-unit | Single-unit<br>Multi-unit | Multi-unit | Single-unit<br>Multi-unit | Single-unit<br>Multi-unit | Single-unit<br>Multi-unit | | Implant/Abutment Interface | External<br>Internal | External<br>Internal | Internal | Internal | One Piece | External | Internal | | Implant Diameter, mm | 2.9 - 6.0 | 3.25 - 6.3 | 3.0 - 5.4 | NA | 2.9 | 3.75 | 4.0 - 4.5 | | Implant Length, mm | 5.0 - 15 | 7.0 - 18 | 6.0 - 17 | NA | 10 - 18 | 8.5 - 15 | 5 - 11 | | Abutment Platform<br>Diameter, mm | 3.3 - 4.8<br>(Prosthetic Ø) | 3.4 - 5.5<br>(Prosthetic Ø) | 3.0 - 5.4 | NP, RP | NA | 3.75 | 4.0 - 6.5 | | Abutment Angle | 0° | 0° - 19° | 0° - 30° | 0° - 30° | 0° | 0° | 0° | | MATERIAL | | | | | | | | | Implant | CPTi Gr 4 | CPTi Gr 4 | CPTi Gr 4 | NA | Titanium Alloy | CPTi Gr 4 | Ti6Al4V | | Surface | Acid-Etched<br>HA | Acid-Etched | OsseoSpeed™ | NA | Unknown | HA | HA, TPS, Integra Ti,<br>NanoTite™ | | Abutment | Ti-6Al-4V<br>CoCr | CPTi Gr 2<br>Ti-6Al-4V<br>CoCr<br>Gold alloy | Ti-6Al-4V<br>Zirconia<br>Gold alloy<br>PEEK | Ti-6Al-4V | NA | Titanium Alloy | Ti-6Al-4V | | Abutment Screw | Ti-6Al-4V | Ti-6Al-4V | Ti-6Al-4V | Ti-6Al-4V | NA | Titanium Alloy | Ti-6Al-4V | {7}------------------------------------------------ The subject device and predicate devices are substantially equivalent in intended use. Minor differences in language in the Indications for Use Statement between the subject device and the predicate devices do not change the intended use of implant placement and function. All are implant systems placed in the maxilla or mandible for single or multi-unit restorations with possible immediate loading for implants shorter than 7 mm is substantially equivalent to the statement in K120414 limiting immediate loading to implants 8 mm or greater. Indications for Use Statements of the above predicates, K101225, K120414, and K081653 include an indication for immediate loading. The phrase, "Restorations supported by two or more Sistema de Implante Nacional implants may be loaded immediately after implant placement if primary implant stability has been achieved" in the primary predicate submission, K051859, has been replaced with the phrase, "S.I.N. Dental Implant System is intended for immediate loading when good primary stability is achieved and with appropriate occlusal loading" as seen for the reference predicate K101225. The phrase, crowns, bridges and overdentures has been replaced with the equivalent statement, "single-unit or multi-unit restorations." Minor changes in language to the Indications for Use Statement do not affect the safety, efficacy or substantial equivalence of the subject device. Subject device implants are substantially equivalent to K051859 implants in body, connection design, material and acid-etched surface. The subject device implant HA surface is substantially equivalent to the K101225 surface treatment. The short implant is substantially equivalent to K092035 in size, surface area and function. Subject device abutments are substantially equivalent to K051859 and K120414 abutments in material, design and function. Subject device multi-unit abutments are substantially equivalent to K072570 abutments in material, design and function. #### CONCLUSION The subject device and the predicate devices have the same intended use, have similar technological characteristics, and are made of similar materials. The subject device and predicate devices encompass the same range of physical dimensions, including diameter, length and angle of the subject and predicate devices are packaged in similar materials and are to be sterilized using similar methods. The data included in this submission demonstrate substantial equivalence to the predicate devices listed above.
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from the tree

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...